Ingudi (Balanites aegyptiaca): Uses, Benefits & Evidence

TL;DR

Ingudi is desert date (Balanites aegyptiaca), an Ayurvedic thorny tree whose fruit was tested in one double-blind pilot (n=30): 400 mg/day of fruit extract for 8 weeks improved fasting and postprandial glucose and lipids in type 2 diabetes. Other evidence is preclinical; human data are limited to this pilot, and no larger replication trial was found in the sources reviewed.

What it is

Ingudi is the Ayurvedic name for Balanites aegyptiaca (L.) Delile, family Zygophyllaceae: a small, spiny, evergreen, drought-tolerant tree with paired thorns and two-leaflet compound leaves, known in English as desert date or Hingot (Sharma & Sharma, J Ayu Int Med Sci 2026). It grows across the arid and semi-arid regions of Africa, the Middle East, and South Asia, including western Rajasthan and peninsular India. Classical synonyms include Hingot, Angarvriksha, Tapasdruma, Tailaphala ("oil-fruit"), and Tiksnakantaka ("sharp-thorned"). Its signature constituents are steroidal saponins (balanitins), flavonoids (quercetin, kaempferol, and myricetin glycosides), phenolic acids, alkaloids, and phytosterols such as β-sitosterol and diosgenin; the seeds yield an oil rich in unsaturated fatty acids.

Traditional use

Classical Ayurvedic texts give Ingudi a clear identity: Charaka Samhita classifies it as a Sirovirechana (head-purgative) drug and places it in the fruit group (Phala Varga), while Sushruta Samhita places it in Arkadi Gana and records actions including Vranshodhana (wound-cleansing), Mraduvirechaka (mild purgative), Krimighna (anthelmintic), Kusthaghna (skin-disease-alleviating), and Sukraghna (anti-fertility) (Sharma & Sharma, JAIMS 2026). Later nighantu texts describe it as Tikta-Katu in taste, Ushna (heating) in potency, balancing Kapha and Vata, and useful in Kustha (skin disorders), Vrana (wounds), Visa (poisoning), and Kapha-Vata disorders, with Krimighna and Medohara (anti-obesity) actions. Folk and classical uses span intestinal worms, skin conditions including leucoderma, wounds, malaria, jaundice, asthma, diarrhoea, dysentery, and haemorrhoids. These are traditional claims, not clinical proof: the human evidence is assessed separately below.

What modern research says

Blood sugar and lipids — the one human pilot trial

Ingudi has something most Ayurvedic herbs lack: a published double-blind, placebo-controlled human trial. In 2017, Egyptian researchers tested a 70% ethanol extract of Balanites aegyptiaca fruit pericarps (400 mg/day in one capsule before lunch) in a randomized, crossover, double-blind, placebo-controlled 8-week pilot of 30 type 2 diabetes patients aged 50–62: most of them on oral antidiabetic drugs (23 of 30), with insulin users excluded (Rashad et al., Pharm Biol 2017). At 8 weeks, the treated group showed a 26.88% fall in 2-hour postprandial plasma glucose (vs. a 2.6% rise with placebo) and a 10.3% fall in fasting glucose. Triglycerides fell 9.0%, total cholesterol 12.76%, LDL 21.35%, HDL rose 29.8%, and liver enzymes ALT/AST fell over 42%: with no reported adverse effects or hypoglycaemia.

Honest framing matters here: this was explicitly a pilot: 30 elderly patients, one center, 8 weeks, one extract. No larger replication trial was identified in the sources reviewed, and a pilot cannot establish Ingudi as a diabetes treatment. It is a genuine signal, not a conclusion.

Preclinical evidence (animals and laboratory studies)

A 2026 systematic review in the Journal of Ayurveda and Integrated Medical Sciences summarizes the rest of the evidence base, all preclinical (Sharma & Sharma, JAIMS 2026):

None of the animal or laboratory findings above have been tested in humans; petri-dish cytotoxicity is not evidence of cancer treatment.

What has not been tested in humans

Beyond the single small diabetes pilot, no published human trial was identified in the sources reviewed for skin disease, wounds, worms, liver disease, malaria, or cancer: the bulk of its reputation still rests on traditional use plus animal and laboratory work.

Dosage

There is no verified Ayurvedic pharmacopoeial dose for Ingudi in the sources consulted. The only human-tested regimen is the one used in the 2017 pilot trial: 400 mg/day of 70% ethanol fruit-pericarp extract in hard gelatine capsules for 8 weeks (Rashad et al., Pharm Biol 2017). That is a standardized research extract given in a clinical setting: not raw fruit, and not a general recommendation.

Safety & contraindications

The short-term picture is reassuring but thin: the pilot trial reported no adverse effects or hypoglycaemia over 8 weeks in 30 patients, and the 2026 systematic review notes animal toxicology studies showing no mutagenic or subacute toxicity at therapeutic doses (Sharma & Sharma, JAIMS 2026). Long-term and high-dose human safety were not addressed in the sources reviewed. Two cautions stand out: pregnancy and conception: no human pregnancy data exist, and animal studies suggest hormonal and antifertility effects, so the cautious course is to avoid Ingudi when pregnant, breastfeeding, or trying to conceive unless a qualified practitioner advises otherwise. And because the fruit extract lowered blood glucose in the pilot, combining Ingudi with diabetes medication carries a theoretical risk of additive hypoglycaemia (no interaction study was found in the sources reviewed). Anyone on medication or managing a medical condition should consult a qualified practitioner rather than self-treat.

FAQs

What is Ingudi?

Ingudi is the Ayurvedic name for Balanites aegyptiaca (L.) Delile, a small spiny evergreen tree of the Zygophyllaceae family also called desert date or Hingot. Classical texts describe it as Tikta-Katu in taste, Ushna in potency, and balancing Kapha-Vata, with traditional uses for worms, skin diseases, and wounds (Sharma & Sharma, JAIMS 2026).

Does Ingudi help diabetes?

One small pilot trial (n=30 Egyptian type 2 diabetes patients) gave 400 mg/day of fruit-pericarp extract for 8 weeks versus placebo: 2-hour postprandial glucose fell ~27%, fasting glucose ~10%, and lipids improved, with no reported adverse effects (Rashad et al., Pharm Biol 2017). This is a pilot, small, short, single-center, not proof; no larger replication trial was identified in the sources reviewed, and Ingudi should not replace diabetes medication.

What is Ingudi traditionally used for?

Ayurvedic texts (Charaka lists it for head purgation; Sushruta's Arkadi group) record Ingudi for worms, skin diseases including leucoderma, wounds, ulcers, and as a mild purgative, with classical actions Krimighna, Kusthaghna, and Medohara (Sharma & Sharma, JAIMS 2026). Folk uses span malaria, jaundice, asthma, diarrhoea, and haemorrhoids. These are traditional claims, not clinical proof: only diabetes has a human pilot trial.

Is Ingudi safe?

In the 8-week pilot trial (n=30), no adverse effects or hypoglycaemia were reported, and animal toxicology found no mutagenic or subacute toxicity at therapeutic doses (Sharma & Sharma, JAIMS 2026). But that is thin safety data: small sample, short duration, one extract. Long-term and high-dose safety in humans are unstudied; anyone on medication or with a medical condition should consult a qualified practitioner first.

Is Ingudi safe in pregnancy?

Not advised. No human pregnancy data exist, and animal studies suggest reproductive effects: ripe-fruit extract raised testosterone and lowered estrogen in male rabbits, while classical texts list Sukraghna (anti-fertility) action (Sharma & Sharma, JAIMS 2026). The cautious course is to avoid Ingudi when pregnant, breastfeeding, or trying to conceive unless a qualified practitioner advises otherwise.

What dose of Ingudi was studied?

The only human-tested regimen: 400 mg/day of 70% ethanol fruit-pericarp extract in capsules for 8 weeks, used in the diabetes pilot (Rashad et al., Pharm Biol 2017). That was a standardized extract in a clinical setting, not raw fruit, and it is a research dose, not a general recommendation; no Ayurvedic pharmacopoeial dose was verified.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.